Shan Ahmed Khan, Author at TechStock²

Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

New York, January 5, 2026, 14:21 EST — Regular session Shares of Viking Therapeutics (VKTX) slid 9.9% to $31.93 in afternoon trading on Monday as obesity-drug stocks reacted to Novo Nordisk’s U.S. launch of a Wegovy weight-loss pill. Novo’s U.S.-listed

5 January 2026

Drug Pricing·Health News·Pharmaceuticals·Stock Market

Wave Life Sciences stock drops 8% as JPM Healthcare Conference looms; obesity data in focus

New York, January 5, 2026, 1:09 PM ET — Regular session Wave Life Sciences Ltd shares fell $1.34, or 8.4%, to $14.61 in afternoon trade on Monday, extending a sharp pullback in the clinical-stage biotech even as the company flagged

5 January 2026

Biotech News·Healthcare Industry·Investment Analysis·Stock Market

Gulfport Energy stock (GPOR) slides nearly 9% on Wolfe downgrade as gas prices fall

New York, Jan 5, 2026, 13:05 EST — Regular session Gulfport Energy Corporation shares fell 8.7% on Monday after Wolfe Research analyst Carlos Escalante cut the U.S. gas producer to Peer Perform from Outperform. The stock traded at $188.26 after

5 January 2026

Analyst Ratings·Energy Sector·Investment·Natural Gas·Stock Market

SiTime stock slumps 9% after topping Wall Street targets, bucking chip rally

New York, Jan 5, 2026, 13:54 EST — Regular session SiTime Corp shares slid about 9% on Monday afternoon, reversing an earlier rise and wiping out a chunk of the timing-chip maker’s start-of-year gains. The Nasdaq-listed stock was down $33.46

5 January 2026

Earnings Reports·Investment·Semiconductors·Stock Market·Technology

Structure Therapeutics stock slides nearly 8% as Novo’s Wegovy pill debut jolts oral obesity-drug bets

NEW YORK, Jan 5, 2026, 13:54 EST — Regular session Structure Therapeutics shares fell 7.7% to $62.86 in afternoon trade on Monday, paring an earlier rally and marking another volatile session for the obesity-drug developer. The stock has ranged from

5 January 2026

Investment News·Pharmaceuticals·Stock Market

Astera Labs stock drops 8% after insider sale plan disclosed — what traders watch next

New York, Jan 5, 2026, 13:45 EST — Regular session Astera Labs shares fell 8.4% to $164.50 on Monday, after swinging from a session high near $185 to a low around $162.5. More than 5 million shares had traded by

5 January 2026

Financial News·Insider Trading·Investing·Stock Market·Trading Strategies

Arrowhead Pharmaceuticals stock slides despite Health Canada approval of Redemplo — what investors watch next

New York, Jan 5, 2026, 13:31 EST — Regular session Arrowhead Pharmaceuticals shares were down about 6.9% on Monday after the company said Health Canada approved Redemplo, its triglyceride-lowering drug for familial chylomicronemia syndrome. The stock fell $4.68 to $63.11

5 January 2026

Company Analysis·Health News·Investing·Pharmaceuticals·Stock Market

AAOI stock slides nearly 11% after $41 pop; what Applied Optoelectronics investors watch next

New York, Jan 5, 2026, 13:30 EST — Regular session Applied Optoelectronics, Inc. (AAOI) shares fell nearly 11% on Monday, erasing an early jump that briefly lifted the stock above $41. The retreat came even as broader U.S. equities and

5 January 2026

Financial News·Investing·Stock Market·Technology Stocks

Lumentum stock drops 8% in sharp reversal as optics peers slide; Feb. 5 earnings loom

New York, Jan 5, 2026, 13:11 (ET) — Regular session Shares of Lumentum Holdings Inc (LITE.O) fell 8.1% to $354.87 on Monday, after trading between $345 and $394.48 in a volatile session. About 4.2 million shares had changed hands by

5 January 2026

Earnings Reports·Investing·Stock Market·Technology

Ciena stock sinks as optics rally cools; traders eye short-interest uptick and next catalysts

New York, Jan 5, 2026, 13:20 EST — Regular session Ciena Corp shares were down about 7.8% at $226.75 in midday New York trading on Monday, after touching $253.30 earlier in the session and then sliding to a low of

5 January 2026

Investor Insights·Market Trends·Stocks·Technology·Trading Strategies

Abivax stock slides 9% in U.S. trade as biotech weakens; ECCO 2026 looms

New York, January 5, 2026, 13:03 EST — Regular session Abivax (ABVX) shares fell about 9.1% to $121.64 in midday U.S. trading on Monday, after touching $133.73 earlier in the session. The stock hit a low of $121.08, while its

5 January 2026

Biotech·Pharmaceuticals·Stock Market

Claire’s and TOFS teeter on administration as UK high street faces fresh jobs shock

London, January 5, 2026, 17:53 GMT Claire’s and The Original Factory Shop (TOFS) are close to filing notices of intention to appoint administrators, a step that would shield the retailers from creditor action while they pursue a rescue, Sky News

5 January 2026

Business News·Employment·UK Economy